Industry in brief | Ipsen, Recordati, Genomma
30 October 2020
France’s Ipsen, Italy’s Recordati and Mexico’s Genomma Labs have recently released financial results.
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
30 October 2020
France’s Ipsen, Italy’s Recordati and Mexico’s Genomma Labs have recently released financial results.
24 July 2020
Recordati’s Fortacin (lidocaine and prilocaine) is set to become the fifth medicine to gain non-prescription status through the European Union’s centralised authorisation procedure.
11 May 2020
Recordati has released financial results, Adare Pharmaceuticals has acquired Orbis Biosciences, and Phynova is raising EUR10 million (USD11 million).
30 March 2020
Two applications to switch medicines from prescription to non-prescription status through the European Union’s centralised authorisation procedure are still in progress.
20 March 2020
Two applications to switch medicines from prescription to non-prescription status through the European Union’s centralised authorisation procedure are set to be discussed by the Committee for Medicinal Products for Human Use (CHMP).
2 August 2019
Recordati, Genomma Lab and Daiichi Sankyo have recently released financial results.